| Country |
Country Information |
Where EC Is Available |
Current Consortium Member Activity |
What Products Are Available |
Prescription Status |
| Afghanistan |
Total Contraceptive Prevalence: 4.8% (2000, WHO) |
Fertilian, a Gedeon Richter product, is available through IPPF's member association in Afghanistan. A dedicated product is not currently registered. EC is not available in the public sector. EC is not available in social marketing/NGO facilities. |
IPPF Affiliate |
- No information on product availability
|
No information available |
 |
| Albania |
Dedicated product registered.
DHS data 2008-09: EC knowledge-28.2%, Ever used EC- 2.4% (all women), 21.7%(Unmarried sexually active women) |
Available without prescription. EC is available in the public sector. EC is available in social marketing/NGO facilities. |
No information available |
- NorLevo 0.75mg
- Postinor-2
|
Available without perscription |
|
| Algeria |
No information available |
No information available |
No information available |
- Pregnon
|
No information available |
|
| Andorra |
No information available |
No information available |
N/A |
- Norlevo 1.5
|
No information available |
|
| Antigua and Barbuda |
No information available |
Pharmacies without a prescription |
IPPF/WHR |
- Optinor
|
Available without a prescription |
|
| Argentina |
Included in the norms in 1999 in the province of Mendoza. A national law was established in 2003 that implemented a national reproductive health care program which includes all
approved contraceptives. EC is included in the emergency room protocal for victims of sexual assault. There are no restrictions in laws, but parental consent is prefered for minors under the age of 14. |
Available in the private and public settings in pharmacies only. |
No information available |
- Norgestrel-Max
- Ovulol
- Postinor 1
- Postinor-2
- Segurite UD
|
Available with unknown requirements |
|
| Armenia |
Dedicated product registered.
DHS Data 2005: Knowledge of EC- 15.6%
Ever used EC- 0.9% (all women), 1.1% (currently married women), n/a
(unmarried sexually active women) |
EC is available in the public sector. EC is not available in social marketing/NGO facilities (no contraceptives available in social marketing/NGO facilities). |
No information available |
- Escapelle
- Postinor
|
Available without prescription |
|
| Aruba |
Dedicated products registered |
Pharmacies without a prescription |
No information available |
- Duet
- Optinor
- Postinor 1
|
Available without a prescription |
|
| Australia |
Dedicated products registered |
Pharmacies without a prescription |
No information available |
- Levonelle-1
- Levonelle-2
- NorLevo 0.75mg
- Postinor 1
- Postinor-2
|
Available without prescription |
|
| Austria |
Dedicated products registered |
Available direct from a Pharmacy without a prescription |
No information available |
- ellaOne
- Postinor
- Postinor 1500
- Vikela
|
Available with a prescription |
|
| Azerbaijan |
Dedicated product registered.
DHS data 2006: Knowledge of EC-4.6%
Ever used EC-0.4% (all women), 0.4% (currently married women) |
EC is not available in the public sector. EC is not available in social marketing/NGO facilities. |
No information available |
- Escapelle
- Postinor
|
Available without prescription |
|
| Bahamas |
No information available |
The FDA approved the OTC use of EC in 2006. Optinor is available OTC and at family planning clinics without a prescription |
IPPF/WHR |
- Optinor
|
No information available |
|
| Bahrain |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Bangladesh |
Postinor-2 registered in 1998 after approval from National Technical Committee. Total Contraceptive Prevalence: 58.1% (2004, WHO) |
Available directly from a pharmacist without a prescription |
Population Council, EngenderHealth, IPPF affiliate (FPAB) |
- Emcon
- Postinor-2
|
Available with prescription |
|
| Barbados |
No documented population policy exists, dedicated product registered |
No information available |
IPPF affiliate, Population Council |
- Optinor
- Postinor-2
|
No information available |
|
| Belarus |
Dedicated product registered |
Levonorgestrel products available at pharmacies without a prescription |
No information available |
- Escapelle
- Postinor
|
Available without prescription |
|
| Belgium |
Dedicated products registered |
Pharmacies without a prescription |
No information available |
- ellaOne
- NorLevo 1.5mg
- Postinor
- Postinor 1
- Postinor 1500
|
Available without a prescription |
|
| Belize |
No information available |
Pharmacies without a prescription |
IPPF/WHR |
- Optinor
|
Available without a prescription |
|
| Benin |
DHS Data 2006: Knowledge of EC- 10.9%
Ever used EC-0.9% (all women), 3.1% (unmarried sexually active women). |
Pharmacies without a prescription, and in public sector clinics |
N/A |
- NorLevo 1.5mg
- Optinor
- Vikela
|
Available without a prescription |
|
| Bermuda |
Not registered |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Bhutan |
EC included in youth norms and country guidelines. |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Bolivia |
Included in MOH norms.
DHS Data 2008: Knowledge of EC-28.3%
Ever used EC-1.6% (all women), 9.7% (unmarried sexually active women) |
Available in pharmacies. EC is not available in the public sector (no contraceptives available in public sector). EC is available in social marketing/NGO facilities. |
Ipas, Pathfinder |
- Glanique
- Imediat N
- Impreviat
- Pilem
- Postinor 1
- Postinor-2
- Pregnon
- Tace
|
Available without prescription |
|
| Botswana |
Total Contraceptive Prevalence: 40.4% (2000, WHO) |
No information available |
No information available |
- No information on product availability
- Optinor
- Pregnon
|
No information available |
|
| Brazil |
Providers, pharmacies with a prescription, free of charge to women in public sector. |
Not Available |
Ipas, IPPF/WHR, Pacific Institute |
- Diad
- Minipil 2
- Nogravide
- Pilem
- Poslov
- Postinor Uno
- Postinor-2
- Pozato
- Pozato Uni
- PPMS
- Previdez 2
- Prevyol
|
Available with a prescription |
|
| Brunei |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Bulgaria |
Dedicated product registered. Total Contraceptive Prevalence: 41.5% (1997, WHO) |
Pharmacies with a prescription |
No information available |
- ellaOne
- Escapelle
- Postinor Duo
|
Available with a prescription |
|
| Burkina Faso |
EC is a component of RH services.
DHS data 2003: Knowledge of EC- 9.4%
Ever used EC-0.4% (all women), 3.1% (unmarried sexually active women). |
Available without a prescription |
IPPF affiliate (ABBEF, ABCEF) |
- NorLevo 1.5mg
- Vikela
|
Available without a prescription |
|
| Cambodia |
DHS Data: Knowledge of EC- 4.9%
Ever used EC: 0.1% (all women), n/a (unmarried sexually active women). |
No information available |
No information available |
- Pregnon
|
No information available |
|
| Cameroon |
Included in MOH sectoral policy in 2001. EC is included in national norms and guidelines for family planning and sexual assault.
DHS Data 2004: Knowledge of EC- 18.7%
Ever used EC-2.6% (all women), 7.4% (unmarried sexually active women) |
Pharmacies without a prescription |
PSI, IPPF/WHR |
- NorLevo 1.5mg
- P2
|
Available without a prescription |
|
| Canada |
Dedicated product registered |
Pharmacies without a prescription. On May 14, 2008, the National Association of Pharmacy Regulatory Authorities (NAPRA) accepted an expert recommendation to change the status of EC, allowing it to be sold in a self-selection area of the pharmacy, close to the dispensary where consultation by a pharmacist is available (Schedule III) |
No information available |
- NorLevo 0.75mg
- Plan B
|
Available without a prescription |
|
| Cape Verde |
DHS Data 2005: Knowledge of EC-28.7%
Ever used EC- 1.3% (all women), 2.7% (unmarried sexually active women) |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Chad |
DHS Data 2004: Knowledge of EC-1.6%
Ever used EC-N/A |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Chile |
Included in FP norms as of 2006, included in Sexual Violence Norms in 2004. |
In April 2008, Constitutional Court ruled in favor of a motion to ban free distribution of EC in public family planning programs and services. EC is still available however, and can be purchased in pharmacies with a medical prescription. EC is also available in primary health clinics (as permitted by local legislation), in public and private hospitals, and emergency care clinics for sexual assault survivors. Levonorgestrel 0.75 was included in the Essential Drug List for MoH in 2006. |
IPPF/WHR |
- Escapel 2
- Escapel-1
- Poslov 0.75
- Post-Day
- Pregnon
|
Available with a prescription |
|
| China |
Dedicated products registered. Total Contraceptive Prevalence: 90.2% (2004, WHO). EC socially marketed by DKT International. |
Widely available at FP clinics, pharmacies without a prescription. LNG EC carries a red label meaning it is available behind the counter from a pharmacist, without a prescription. However, they are effectively available over the counter. |
WHO/HRP |
- Ai Wu You
- An Ting 0.75mg
- An Ting 1.5mg
- Bao Shi Ting (Postinor-2, 0.75mg)
- Bao Shi Ting 1.5
- Bi Yun (10mg)
- Bi Yun (12.5mg)
- Bi Yun (25mg)
- Dan-Mei (0.75 mg)
- Dan-Mei (1.5 mg)
- Fang Xin
- Fu Nai Er (10 mg)
- Fu Nai Er (25 mg)
- Hou Ding Nuo (10 mg)
- Hou Ding Nuo (25 mg)
- Hua Dian (10 mg)
- Hua Dian (25 mg)
- Hui Ting 0.75mg
- Hui Ting 1.5mg
- Jin Xiao (0.75 mg)
- Jin Xiao (1.5 mg)
- Jin Yu Ting
- Ka Rui Ding
- Le Ting
- Nuo Shuang
- Postinor-2
- Si Mi An (10 mg)
- Si Mi An (25 mg)
- Xian Ju
- Yi Ting
- Yu Ping
- Yu Ting
|
Available without a prescription |
|
| Colombia |
Included in family planning & sexual violence norms, dedicated products registered in 2005.
DHS Data 2005: Knowledge of EC- 40.8%
Ever used EC- 3.2% (all women), 10.1% (unmarried sexually active women). |
Pharmacies with a prescription. EC not available in the public sector. EC socially marketed by PROFAMILIA |
IPPF/WHR |
- EMERGYN
- Escinor 1.5
- Post-Day
- Post-Day 1
- Post-Day 2
- Postinor 1
- Postinor-2
- Pregnon
- Tace
|
Available with a prescription |
|
| Congo (Republic of, Brazzaville) |
Registered in 2001.
DHS date 2007: Knowledge of EC- 30.2% (all women)
Ever used EC- 12.0% (all women), 13.1% (currently married women), 18.1% (unmarried sexually active women) |
without a prescription |
IPPF affiliate |
- NorLevo 1.5mg
- Vikela
|
Available from a pharmacist without a prescription |
|
| Costa Rica |
No EC product approved. EC not included in norms and policies. Total Contraception Prevalence: 80% (1999, WHO) |
OCs are available and could be used for Yuzpe method, but knowledge is low. |
No information available |
- No dedicated EC product available.
|
No information available |
|
| Croatia |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Cuba |
Included in FP norms, Postinor-2 registered. Total Contraceptive Prevalence: 73.3% (2000, WHO) |
Public health clinics free of charge |
No information available |
- Postinor
|
Available with prescription |
|
| Curacao |
No information available |
Available over the counter in clinics only |
No information available |
- Duet
- Optinor
- Postinor 1
|
Available without prescription |
|
| Cyprus |
Dedicated product registered |
Pharmacies without a prescription |
No information available |
- ellaOne
- NorLevo 1.5mg
|
Available without a prescription |
|
| Czech Republic |
Dedicated product registered. Total Contraceptive Prevalence: 72.0% (1997, WHO) |
Levonorgestrel products available at pharmacies without a prescription |
No information available |
- ellaOne
- Escapelle
- Postinor-2
|
Available without prescription |
|
| Denmark |
Dedicated products registered |
Pharmacies without a prescription |
No information available |
- ellaOne
- Levonelle 1500
- NorLevo 1.5mg
- Postinor
|
Available without a prescription |
|
| Djibouti |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Dominica |
No information available |
No information available |
No information available |
- Optinor
- Postinor 1
|
No information available |
|
| Dominican Republic |
Included in National RH Guidelines in 1999.
DHS Data 2007: Knowledge of EC-45.3%
Ever used EC: 2.7% (all women), 6.5% |
IPPF affiliate, at pharmacies IPPF affiliate, at pharmacies for $5. EC is not available in the public sector. EC is available in social marketing/NGO facilities. |
IPPF/WHR |
- Evital
- Glanique
- Imediat N
- Impreviat
- Post-Day
- Postinor 1
- Pregnon
- Seguidet
|
Available without a prescription |
|
| East Timor |
DHS Data 2009: Knowledge of EC- 12.3%
Ever used EC- 0% (all women) |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Ecuador |
Registered in 2004. Included in National FP norms and Sexual Violence Norms. Constitutional Court case ruled against EC in May 2006. The registered products listed here are not available on the market at this time. Total Contraceptive Prevalence: 65.9% (1997, WHO) |
Available in pharmacies as of Feb. 2007 |
Pathfinder, CEPAM |
- Escapel
- Glanique
- Glanique 1
- Impreviat
- Post-Day
- Pregnon
- Tace
|
Available without prescription |
|
| Egypt |
DHS Data 2008: Knowledge of EC-5.6%
Ever used EC-0.1% (all women), N/A (unmarried sexually active women) |
EC socially marketed by DKT International. |
No information available |
- Contraplan II
- Postinor-2
|
unknown |
|
| El Salvador |
EC is included in sexual and reproductive health norms but not in sexual violence norms.
The regulatory framework ensures free access, but there are still critcal availabilty problems. |
Available from a pharmacist without a prescription.
No public sector access. |
No information available. |
- Postinor
|
No information available. |
|
| Equatorial Guinea |
DHS Data 2005: Knowledge of EC-3.9%
Ever used EC-0.2% (all women), 1.4% (unmarried sexually active women) |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Eritrea |
DHS Data 2002: Knowledge of EC-10.4%
Ever used EC-0.4% (all women), 0% (unmarried sexually active women) |
No information available |
JSI |
- No information on product availability
|
No information available |
|
| Estonia |
Dedicated products registered |
Pharmacies without a prescription |
No information available |
- Escapelle
- Postinor Duo
- Postinor-2
|
Available without a prescription |
|
| Ethiopia |
Total Contraceptive Prevalence: 14.7% (2005, WHO). Current unmet need for contraception among currently married women: 34% (2005, DHS). EC socially marketed by DKT International. |
EC is available in the public sector. EC is available in social marketing/NGO facilities. Available through DKT distribution network. |
IPPF/WHR, DKT |
- Postinor-2
- Postpill
|
unknown |
|
| Fiji |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Finland |
NorLevo registered |
Pharmacies without a prescription |
No information available |
- ellaOne
- NorLevo 1.5mg
- Postinor 1500
|
Available without a prescription |
|
| France |
Included in MOH guidelines, Norlevo 1.5mg replaced NorLevo 0.75mg in Oct 2004. |
EC is available at pharmacies without a prescription. The cost can be reimbursed when dispensed upon prescription by a physician or a midwife. EC is free of charge for minors and will be dispensed anonymously from pharmacies and will be free of charge (the pharmacist will be paid directly by insurance). EC is also available in family planning centers and high schools, where it is delivered by nurses.
|
No information available |
- Anthia
- ellaOne
- Levonorgestrel Biogaran 1500 microgram
- NorLevo 1.5mg
|
Available without a prescription |
|
| French Guiana |
no information available |
no information available |
n/a |
- ellaone
- NorLevo 1.5
|
no information available |
|
| French Polynesia |
No dedicated products registered |
Ecv is not available |
N/A |
- No information available
|
No information available |
|
| Gabon |
NorLevo registered. According to 2001 DHS, 17% of currently married women know of EC. Total Contraceptive Prevalence: 32.7% (2000, WHO) |
Pharmacies without a prescription |
No information available |
- NorLevo 1.5mg
- Vikela
|
Available without a prescription |
|
| Georgia |
Dedicated product registered. Total Contraceptive Prevalence: 47.2% (2005, WHO) |
EC is available in the public sector. EC is not available in social marketing/NGO facilities (no contraceptives available in social marketing/NGO facilities). |
No information available |
- Escapelle
- Postinor
|
Available with prescription |
|
| Germany |
Dedicated products registered |
unknown |
No information available |
- ellaOne
- PiDaNa
|
Pharmacies with a prescription. Non-prescription application denied in 2004. |
|
| Ghana |
Included in National RH Service Policy in April 1996.
DHS Data 2008: Knowledge of EC-35.4%
Ever used EC- 2.9% (all women), 6.7% (unmarried sexually active women) |
Available in pharmacies and clinics. EC is available in the public sector. EC is also available in social marketing/NGO facilities. |
Pathfinder, Meridian |
- NorLevo 1.5mg
- Pregnon
|
Available without a prescription |
|
| Greece |
Dedicated products registered |
Pharmacies without a prescription |
No information available |
- ellaOne
- NorLevo 1.5mg
- Postinor
- Postinor 1500
|
Available without a prescription |
|
| Grenada |
Not registered |
No information available |
No information available |
- No information on product availability
- Optinor
|
No information available |
|
| Guatemala |
Included in Reproductive Health Norms, Postinor registered in 2007. Total Contraceptive Prevalence: 43.3% (2002, WHO). EC socially marketed by APROFAM. |
EC is available in the public sector. EC is also available in social marketing/NGO facilities. |
No information available |
- Postinor 1
|
No information available |
|
| Guinea-Conakry |
NorLevo registered in 2001. Total Contraceptive Prevalence: 9.1% (2000, WHO) |
Pharmacies without a prescription |
JSI, IPPF affiliate (AGBEF) |
- NorLevo 1.5mg
|
Available without a prescription |
|
| Guyana |
Total Contraceptive Prevalence: 37.3% (2000, WHO) |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Haiti |
Included in National FP norms.
DHS Data 2005-06: Knowledge of EC-13.2%
Ever used EC-0.3% (all women), 1.1% (unmarried sexually active women). |
Soon to have non-prescription status. EC is not available in the public sector. EC is not available in social marketing/NGO facilities. |
PSI |
- No information on product availability
|
Available with unknown requirements |
|
| Honduras |
EC was banned by a presidential decree in Honduras in October 2009. The current law prohibits sale and use of EC. The dedicated products listed below are not available on the market.
DHS data 2005-06: Knowledge of EC- 34.9%
Ever used EC-1.2% (all women), 5.2% (unmarried sexually active women). |
The current law prohibits sale and use of EC. |
Population Council, IPPF affiliate, PSI |
- Plan B
- Pregnon
|
No information available |
|
| Hong Kong |
Postinor-2 registered in 2002 |
Clinics, pharmacies, hospitals |
IPPF affiliate |
- Duet
- Escapelle
- Estinor
- Postinor-2
|
Available without prescription |
|
| Hungary |
Dedicated product registered |
Available with a prescription |
No information available |
- ellaOne
- Escapelle
- Rigesoft
|
Available without prescription |
|
| Iceland |
Dedicated products registered |
Doctors, school nurses, pharmacies without a prescription |
No information available |
- NorLevo 1.5mg
- Postinor
- Postinor 1.5 mg
|
Available without a prescription |
|
| India |
Included in MOH guidelines.
DHS Data 2005-06: Knowledge of EC- 16.1% |
Over-the-counter in pharmacies. EC is available in the public sector. EC is available in social marketing/NGO facilities. EC socially marketed by Population Services International and Marie Stopes International. |
Marie Stopes, IPPF affiliate (FPA India), EngenderHealth |
- E Pills
- ECee2
- i-pill
- NorLevo 0.75mg
- Pill 72
- Postinor-2
- Preventol
|
Available without a prescription |
|
| Indonesia |
Safety approval from BKKBN.
DHS Data 2007: Knowledge of EC- 6.3% (ever married women)
Ever used EC- 0.3% (ever married women), n/a (unmarried sexually active women). |
FP clinics, pharmacies with a prescription. EC socially marketed by DKT International. |
Pacific Institute, PATH |
- Postinor-2
|
Available with a prescription |
|
| Iran |
Total Contraceptive Prevalence: 78% (2004) 60% of CPR use is modern methods, 18% natural or traditional methods. |
EC is available in the private sector for about $0.1 under the name Levonil. It is available in the public sector free of charge, under the name Levonorgestrel. It is included in family planning norms, guidelines, and curriculum. |
Not Available |
- Levonorgestrel
- Longil
- Ovocease
|
No prescription needed. |
|
| Iraq |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Ireland |
NorLevo 1.5mg replaced NorLevo 0.75mg in Oct 2004, other dedicated products registered. As of spring 2011, EC is available in pharmacies without a prescription. |
Available in pharmacies without a prescription |
No information available |
- Levonelle
- Levonelle 1500
- NorLevo 1.5mg
|
Available in pharmacies without a prescription, over the counter. |
|
| Israel |
Postinor-2 granted non-prescription status in November 2001. The generic NorLevo was registered in 2010. |
Pharmacies without a prescription and family planning clinics |
No information available |
- NorLevo 1.5mg
- Postinor New
- Postinor-2
|
Available without a prescription |
|
| Italy |
Dedicated products registered |
Not Available |
Not Available |
- Levonelle
- LONEL
- NorLevo 1.5mg
- Unlevo 1500 microgrammi compressa
|
Available |
|
| Ivory Coast |
Total Contraceptive Prevalence: 15% (1998-1999, WHO) |
Pharmacies without a prescription |
IPPF/WHR and IPPF affiliate (AIBEF) |
- NorLevo 1.5mg
- P2
|
Available without a prescription |
|
| Jamaica |
Included in family planning norms. Total Contraceptive Prevalence: 65.9% (1997, WHO) |
Pharmacies without a prescription |
IPPF affiliate, Population Council |
- Postinor 2 SD
- Postinor-2
- Pregnon
- Pregnon 1.5
|
Available without a prescription |
|
| Japan |
Total Contraceptive Prevalence: 55.9% (2000, WHO) |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Jordan |
Combined and progestin-only oral contraceptive pills are widely available, so in theory the Yuzpe method is available, but we have no information about knowledge and use.
DHS Data 2009: Knowledge of EC- 15.7% (ever married women)
Ever used EC- 0.5% (ever married women), n/a (unmarried sexually active women). |
No information available |
No information available |
- No dedicated EC product available.
|
No information available |
|
| Kazakhstan |
Dedicated product registered.
DHS Data 1999: Knowledge of EC-33.4%
Ever used EC- 2.2% (all women), 5% (unmarried sexually active women). |
Available without prescription |
No information available |
- Escapel
- Escapelle
- Postinor
|
Available without prescription |
|
| Kenya |
Included in national family planning & RH Service Guidelines.
DHS Data 2008-09: Knowledge of EC-40.2%
Ever used EC-1.7% (all women), 10.9% (unmarried sexually active women) |
EC is available from private providers and in pharmacies without a prescription. EC is available in the public sector and in social marketing/NGO facilities. EC socially marketed by Marie Stopes International. |
Population Council, EngenderHealth, PATH, IPPF Affiliate
(FHOK) |
- ECee2
- Escinor 1.5
- P2
- Postinor-2
- Pregnon
- Pregnon (Smart Lady)
|
Available without a prescription |
|
| Kiribati |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Kuwait |
No information available |
No information available |
No information available |
- No dedicated EC product available.
|
No information available |
|
| Kyrgystan |
Dedicated product registered. Total Contraceptive Prevalence: 59.5% (1997, WHO) |
No information available |
No information available |
- Escapelle
- Postinor
|
Available without a prescription |
|
| Laos |
MOH has not granted permission to import. Total Contraceptive Prevalence: 32.2% (2000, WHO) |
Availability at pharmacies |
No information available |
- Duet
- No information on product availability
|
Available with unknown requirements |
|
| Latvia |
Dedicated products registered |
Pharmacies without a prescription |
No information available |
- ellaOne
- Escapelle
- Postinor Duo 750 micrograms tablets
- Postinor-2
|
Available without a prescription |
|
| Lebanon |
NorLevo available since 2002 |
Pharmacies with a prescription |
No information available |
- NorLevo 1.5mg
|
Available with a prescription |
|
| Liechtenstein |
No information available |
No information available |
No information available |
- NorLevo 1.5mg
|
No information available |
|
| Lithuania |
Dedicated products registered |
Levonorgestrel products available at pharmacies without a prescription |
No information available |
- ellaOne
- Escapelle
- Postinor-2
|
Available with a prescription |
|
| Luxembourg |
Dedicated products registered |
Pharmacies without a prescription |
No information available |
- ellaOne
- NorLevo 1.5mg
- Postinor
- Postinor 1500
|
Available without a prescription |
|
| Macedonia |
No information available |
No information available |
N/A |
- Norlevo 1.5
|
No information available |
|
| Madagascar |
Approved by MOH, Dedicated products registered. According to 2001 DHS, 6% of currently married women know of EC. Total Contraceptive Prevalence: 27.1% (2003-2004, WHO). Unmet need for contraception among currently married women: 24% (2004, DHS). |
Available in pharmacies with a prescription. EC is not available in the public sector or in social marketing/NGO facilities. |
IPPF affiliate, PSI |
- NorLevo 1.5mg
- Pill 72
- Pregnon
|
Available with a prescription |
|
| Malawi |
According to 2001 DHS, 22% of married women know of EC. Total Contraceptive Prevalence: 32.5% (2004, WHO). Unmet need for contraception among currently married women: 28% (2004, DHS). |
EC is not available in the public sector. EC is not available in social marketing/NGO facilities. |
IPPF/WHR |
- Pregnon
|
No information available |
|
| Malaysia |
Included in MOH family planning guidelines |
Pharmacies with a prescription |
No information available |
- Ella
- Escapelle
- Estinor
- Me Tablet 0.75 mg
- Postinor
- Postinor-2
- Pregnon
|
Available with a prescription |
|
| Maldives |
DHS Data 2009: Knowledge of EC- 29% (ever married women)
Ever used EC- 0.6% (ever married women), n/a (unmarried sexually active women) |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Mali |
DHS data 2006: Knowledge of EC-9.4%
Ever used EC- 0.2% (all women) 0.6% (unmarried sexually active women) |
available from a pharmacist without a prescription |
N/A |
- NorLevo 1.5mg
- Optinor
- Pregnon
- Vikela
|
Available without a prescription |
|
| Malta |
MoH refusal to grant MA |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Marshall Islands |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Martinique |
No information available |
No information available |
N/A |
- ellaone
- NorLevo 1.5 mg
|
No information available |
|
| Mauritania |
No national family planning policy or program exists at present.
DHS data 200-01: Knowledge of EC- 4.6%
Ever used EC- N/A |
Pharmacies without a prescription |
No information available |
- NorLevo 1.5mg
|
Available without a prescription |
|
| Mauritius |
Included in family planning norms Oct 2004, NorLevo registered in 2001. Total Contraceptive Prevalence: 75.9% (2002, WHO) |
Pharmacies without a prescription |
No information available |
- NorLevo 1.5mg
- Pregnon
|
Available without a prescription |
|
| Mexico |
Included in family planning norms Oct 2004, incorporated into the basic Medical Guidelines in 2005. Dedicated products registered. Total Contraceptive Prevalence: 68.4% (1997, WHO). EC socially marketed by DKT International. |
IPPF affiliate clinics, pharmacies, required to be in-stock at public facilities, available without a prescription to minors |
DKT, PIWH, Population Council |
- Alterna
- Dreams
- Glanique
- Hispratel
- Ladiades 0.75
- Ladiades 1.5
- Oportuna
- Post-Day
- Postinor-2
- Postinor-2 Unidosis
- Silogin 0.75mg
- Silogin 1.5mg
- Vika
|
Available without a prescription |
|
| Micronesia |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Moldova |
Dedicated product registered.
DHS Data 2005: Knowledge of EC- 38.1%
Ever used EC- 3.0%, 3.4% (currently married women), 8.9% (unmarried sexually active women) |
No information available |
No information available |
- Escapelle
- Postinor
|
No information available |
|
| Monaco |
No information available |
available from a pharmacist without a prescription |
No information available |
- ellaone
- NorLevo 1.5 mg
|
No information available |
|
| Mongolia |
Dedicated product registered. Total Contraceptive Prevalence: 67.4% (2000, WHO). EC socially marketed by Marie Stopes International. |
Pharmacies and private providers |
IPPF affilate, UNFPA |
- Postinor
- Pregnon
|
Available without prescription |
|
| Morocco |
Dedicated products registered; 2008. Total Contraceptive Prevalence: 63% (2003-2004, WHO) |
Health centers |
IPPF affiliate |
- NorLevo 1.5mg
- Postinor-2
|
Available with unknown requirements |
|
| Mozambique |
No specific regulations exist. Total Contraceptive Prevalence: 16.5% (2003-2004, WHO) |
No information available |
Pathfinder, PSI |
- No information on product availability
|
No information available |
|
| Myanmar (Burma) |
Approved by National Formulary in 1995, dedicated product registered. Total Contraceptive Prevalence: 37% (2001, WHO). EC socially marketed by Marie Stopes International and Population Services International. |
Pharmacies, clinics and private providers |
PSI |
- Duet
- ECee2
- Pill 72
- Postinor
- Postinor-2
- Pregnon
|
Officially, EC is available with prescription |
|
| Namibia |
No information available |
No information available |
No information available |
- NoLevo 1.5 mg
- Optinor
|
No information available |
|
| Nauru |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Nepal |
DHS Data 2006: Knowledge of EC- 7.4%
Ever used EC- 0.1% (currently married women), n/a (unmarried sexually active women). |
EC is available in social marketing/NGO facilities and the public sector. EC socially marketed by Nepal Social Marketing and Franchise Project. |
No information available |
- Pregnon
|
No information available |
|
| Netherlands |
NorLevo registered |
Without a prescription in pharmacies, drugstores |
No information available |
- ellaOne
- NorLevo 1.5mg
- Postinor 1500
|
Available without prescription (OTC) |
|
| Netherlands Antilles |
Dedicated product registered |
No information available |
No information available |
- Postinor 1
|
No information available |
|
| New Zealand |
Dedicated products registered |
Pharmacies without a prescription |
No information available |
- Levonelle
- Levonelle-1
- Postinor 1
- Postinor-2
|
Available without a prescription |
|
| Nicaragua |
Included in National FP norms in 1997.
DHS Data 2001: Knowledge of EC- 21.4%
Ever used EC- 1.2% (all women), 5.8% (unmarried sexually active women). |
Few providers, available in pharmacies. EC is not available in the public sector. EC is not available in social marketing/NGO facilities. |
Ipas, PATH, Pacific Institute |
- PPMS
- Prikul
|
Available without prescription |
|
| Niger |
Total Contraceptive Prevalence: 14% (2000, WHO) |
Pharmacies without a prescription |
No information available |
- NorLevo 1.5mg
- Pregnon
|
Available without a prescription |
|
| Nigeria |
EC is not included in National family planning or sexual violence protocols.
DHS data 2008: Knowledge of EC-15.4%
Ever used EC- 2.8% (all women), 15.5% (unmarried sexually active women). |
Pharmacies, clinics. EC is not available in the public sector. EC is available in social marketing/NGO facilities. EC is socially marketed by Society for Family Health with technical assistance from Population Services International. |
WHO/HRP, EngenderHealth, IPPF affiliate, PSI affiliate |
- Postinor
- Postinor-2
- Pregnon
|
Available without a prescription |
|
| Norway |
Dedicated products registered |
Pharmacies without a prescription directly off the shelf |
No information available |
- ellaOne
- NorLevo 1.5mg
- Postinor
- Postinor 1.5 mg
|
Available without a prescription (OTC) |
|
| Oman |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Pakistan |
Dedicated product registered.
DHS Data 2006-07: Knowledge of EC- 17.8%
Ever used EC- 0.9% (currently married women). n/a (unmarried sexually active women). |
Pharmacies, Greenstar FP Clinics. EC is available in the public sector. EC socially marketed by Population Services International and Greenstar Social Marketing |
PSI |
- EC
- ECP
- Emkit
- Emkit Plus
- Postinor-2
|
Available with prescription |
|
| Palau |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Palestine (West Bank and Gaza Strip) |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Panama |
No registered product available, however EC is included in sexual and reproductive health norms.
The regulatory framework ensures access but there is still no product available. |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Papua New Guinea |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Paraguay |
Included in national family planning norms in 1998. Total Contraceptive Prevalence: 72.8% (2004, WHO). EC socially marketed by Population Services International. |
Pharmacies with a prescription, private providers. EC is available and free of charge for women in the public sector. EC is available in social marketing/NGO facilities. |
PSI |
- Control NF
- Imediat N
- Postinor-2
- Pregnon
- Pronta
|
Available with a prescription |
|
| Peru |
Included in family planning (2001) and Sexual Violence norms (date unknown).
DHS Data 2004-08: Knowledge of EC- 41.2%
Ever used EC- 1.1% (all women), 2.2 (unmarried sexually active women). |
Available with a prescription.No access in the public sector.
EC socially marketed by APPRENDE. Many EC brands available in pharmacies. |
N/A |
- Auxxil
- D-Sigyent
- Dia S MP
- Emkit
- Escapel 1.5
- Glanique
- Glanique 0.75
- Glanix
- Gynotrel 2
- Impreviat
- Inmediat
- L Novafem
- Lenor 72
- Mergynex
- Nogestrol
- Nortrel 2
- Novanor 2
- Pill 72
- Pillex
- Post-Day
- Postinor 1
- Postinor-2
- Pregnon
- Prevemb
- Preventol
- Tibex
- Velor 72
- Zintemore
|
Available with a prescription |
|
| Philippines |
Postinor "delisted" by BFAD in 12/01.
DHS Data 2008: Knowledge of EC- 9.7%
Ever used EC- 0.3% (currently married women), n/a (unmarried sexually active women) |
EC is not available |
Pacific Institute |
- No EC product currently available.
|
No information available |
|
| Poland |
Dedicated product registered |
No information available |
No information available |
- ellaOne
- Escapelle
- Postinor Duo
|
No information available |
|
| Portugal |
Dedicated products registered |
Pharmacies without a prescription |
No information available |
- ellaOne
- NorLevo 1.5mg
- Postinor
- Postinor 1500
|
Available without a prescription |
|
| Puerto Rico |
no information |
available from a pharmacist without a prescription |
N/A |
- NextChoice
|
available without a prescription |
|
| Qatar |
Total Contraceptive Prevalence: 43.2% (1998, WHO) |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Republic of Korea |
Approved by Pharmaceautical Safety Bureau. Total Contraceptive Prevalence: 80.5% (1997, WHO) |
Available in pharmacies with a prescription. |
No information available |
- After 1
- Levonia
- Levonormin
- MS pill
- NorLevo 1.5mg
- Postinor 1
- Sexcon 1&1
|
Available with a prescription |
|
| Romania |
Dedicated product registered. Total Contraceptive Prevalence: 63.8% (1999, WHO) |
Levonorgestrel products available at pharmacies without a prescription |
No information available |
- ellaOne
- Escapelle
- Postinor-2
|
Available without prescription |
|
| Russia |
Dedicated products registered. Total Contraceptive Prevalence: 72.8% (1999, WHO) |
EC is available in the public sector. EC is not available in social marketing/NGO facilities. |
No information available |
- Escapel
- Escapelle
- Escinor 0.75/1.5
- Postinor
|
Available with unknown requirements |
|
| Saint Kitts and Nevis |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Saint Lucia
|
No information available |
Available over the counter through emergency units and private and public pharmacies. SLPPA sole distributor, in drug formulary. |
IPPF/WHR |
- Optinor
|
Available without a prescription |
|
| Samoa |
DHS Data 2009:Knowledge of EC- 4.7%
Ever used EC- 0.1% (all women), 0.2% (currently married women), n/a (unmarried sexually active women) |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| San Marino |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Saudi Arabia |
While a product is registered in Saudi Arabia, it is generally not available. |
No information available |
No information available |
- Postinor-2
|
No information available |
|
| Senegal |
DHS Data 2005: Knowledge of EC-9.6%
Ever used EC- 0.2% (all women), 0% (unmarried sexually active women) |
Pharmacies without a prescription. EC is available in the public sector. EC is not available in social marketing/NGO facilities. |
IPPF affiliate, Population Council |
- Duet
- NorLevo 1.5mg
|
Available without a prescription |
|
| Serbia/Montenegro |
Dedicated product registered. Total Contraceptive Prevalence: 58.3% (2000, WHO) |
Available without prescription |
No information available |
- Escapelle tablets
- Postinor-2
|
Available without prescription |
|
| Seychelles |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Sierra Leone |
DHS Data 2008: Knowledge of EC-6.2%
Ever used EC-1.1% (all women), 5.4% (unmarried sexually active women) |
No information available |
No information available |
- Pregnon
|
No information available |
|
| Singapore |
Regulated, no MOH guidelines, Estinor and NorLevo registered. Total Contraceptive Prevalence: 62% (1997, WHO) |
Pharmacies with a prescription |
No information available |
- Ella
- Estinor
- Postinor-2
|
Available with a prescription |
|
| Slovakia |
Dedicated products registered |
Pharmacies without a prescription |
No information available |
- ellaOne
- Escapelle
- Postinor-2
|
Available without a prescription |
|
| Slovenia |
No information available |
Levonorgestrel products available at pharmacies without a prescription |
No information available |
- ellaOne
- Escapelle 1.5 mg tableta
- NorLevo 0.75mg
|
Available without a prescription |
|
| Solomon Islands |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Somalia |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| South Africa |
EC is now considered an integral part of the national contraception strategy.
DHS Data 2003: Knowledge of EC-19.6%
Ever used EC-0.5% (all women), 0.5% (unmarried sexually active women) |
Pharmacies without a prescription, public clinics |
IPPF affiliate, Population Council |
- Escapel
- Escapelle
- NorLevo 0.75mg
|
Available without a prescription |
|
| Spain |
Dedicated products registered |
Since 2009, EC is available in Spain without a prescription. |
No information available |
- ellaOne
- NorLevo 1.5mg
- Postinor
- Postinor 1500
|
No prescription required. |
|
| Sri Lanka |
NorLevo and Postinor-2 registered in 1997. Total Contraceptive Prevalence: 70% (2000, WHO). EC socially marketed by the Family Planning Association of Sri Lanka and Marie Stopes International. |
Pharmacies without a prescription, public and private clinics |
IPPF affiliate |
- Emcon
- Madonna
- Pill 72
- Postinor-2
- Pregnon
|
Available without a prescription |
|
| Sudan |
Some dedicated EC product available from UN in rape kits. EC is only approved for use in cases of rape. Often Yuzpe method is used. |
No information available |
No information available |
- No dedicated EC product available.
|
No information available |
|
| Suriname |
Total Contraceptive Prevalence: 42.1% (2000, WHO) |
No information available |
No information available |
- Postinor 1
- Pregnon
|
No information available |
|
| Swaziland |
DHS data 2006-07: Knowledge of EC-25.7%
Ever used EC-2.6% (all women), 6.0% (unmarried sexually active women). |
No information available |
No information available |
- NorLevo 0.75
|
No information available |
|
| Sweden |
Dedicated products registered |
Over-the-counter in pharmacies |
No information available |
- ellaOne
- NorLevo 1.5mg
- Postinor
- Postinor 1.5 mg
|
Available without a prescription |
|
| Switzerland |
Dedicated products registered |
EC has been available in pharmacies without a prescription since 2001, for women 16 and older. Pharmacist counsels woman personally. |
No information available |
- NorLevo 1.5mg
|
Available without a prescription |
|
| Syria |
No information available |
No information available |
No information available |
- No dedicated EC product available.
|
No information available |
|
| Taiwan |
NorLevo currently undergoing a re-registration process. Postinor-2 registered in 2002. |
Pharmacies with a prescription |
No information available |
- Escapelle
- NorLevo 1.5mg
- Postinor-2
|
Available with a prescription |
|
| Tajikistan |
Dedicated product registered. Total Contraceptive Prevalence: 33.9% (2003, WHO) |
Pharmacies without prescription |
No information available |
- Escapelle
- Postinor
|
Available without a prescription |
|
| Tanzania |
Included in family planning practice guidelines.
DHS Data 2004-05: Knowledge of EC-9.4%
Ever used EC-0.2% (all women), 0.4% (unmarried sexually active women) |
Providers & youth services. EC is not available in the public sector. EC is not available in social marketing/NGO facilities. |
PSI |
- P2
|
Available without a prescription |
|
| Thailand |
National family planning program, but MOH supportive, Madonna registered. Total Contraceptive Prevalence: 72.2% (1996-1997, WHO) |
Hospitals, pharmacies without a prescription |
Population Council, JSI |
- Madonna
- Postinor
- Postinor-2
|
Available without a prescription |
|
| Togo |
Total Contraceptive Prevalence: 25.7% (2000, WHO). Unmet need for contraception among married women of reproductive age: 40.6% (2006, Multiple Indicator Cluster Survey). |
No information available |
No information available |
- NorLevo 1.5mg
|
Available without a prescription |
|
| Tonga |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Trinidad and Tobago |
Postinor-2 registered. Total Contraceptive Prevalence: 38.2% (2000, WHO) |
FP clinics & most pharmacies |
Population Council |
- Postinor 2 SD
- Postinor-2
|
Available with unknown requirements |
|
| Tunisia |
No information available |
No information available |
No information available |
- NorLevo 1.5mg
|
Available directly from pharmacist without prescription |
|
| Turkey |
Dedicated products registered.
DHS Data 2003; Knowledge of EC- 16.2%
Ever used EC- 0.6% (currently married women), n/a (unmarried sexually active women) |
Pharmacies without a prescription |
No information available |
- NorLevo 0.75mg
|
Available without a prescription |
|
| Turkmenistan |
DHS Data 2000: Knowledge of EC- 7.7%
Ever used EC- 0.2% (all women), 0.4% (currently married women), n/a (unmarried sexually active women) |
No information available |
No information available |
- Escapelle
- Postinor
|
No information available |
|
| Tuvalu |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Uganda |
EC is included in the family planning guidelines. In May 2002, a PSI campaign ended and Vikela was no longer available in the public or private sectors.
DHS data 2006: Knowledge of EC- 13.6%
Ever used EC- 0.3% (all women), 0% (unmarried sexually active women) |
EC is available in the private and public sectors. EC is available in social marketing/NGO facilities. |
Pop Council and ECafrique |
- P2
|
No information available |
|
| Ukraine |
DHS data 2007: Knowledge of EC- 48.5%
Ever used EC- 4.9% (all women), 15% (unmarried sexually active women) |
Available without prescription. EC is not available in the public sector. EC is not available in social marketing/NGO facilities. |
No information available |
- Escapelle
- Escapelle 1.5
- Postinor
|
Available without prescription |
|
| United Arab Emirates |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| United Kingdom |
Dedicated product registered. Total Contraceptive Prevalence: 84% (2002, WHO) |
EC is available at pharmacies without a prescription, though some pharmacists will not provide EC to women under 16. Pharmacist will see the woman before issuing. |
No information available |
- ellaOne
- Levonelle 1500
- Levonelle One Step
- Levonelle-2
|
Available without a prescription |
|
| United States |
Dedicated product registered. Total Contraceptive Prevalence: 72.9% (2002, WHO) |
Plan B One-Step and Next Choice are available in pharmacies without a prescription for those 17 and older. They are both available with a prescription for those 16 and younger. ella is available with a prescription. |
American Society for Emergency Contraception |
- ella
- Next Choice
- Plan B One-Step
|
Available without a prescription for 17 year olds and older. Available with a prescription for 16 year olds and younger. |
|
| Uruguay |
No formal FP norms exist |
Available without a prescription. Not available in publich sector. |
No information available |
- Evitarem
- Imediat N
- Postinor-2
- Prikul
- Secufem
|
No information available |
|
| Uzbekistan |
Dedicated product registered. According to 2001 DHS, 10% of currently married women know of EC. Total Contraceptive Prevalence: 67.7% (2002, WHO) |
No information available |
No information available |
- Escapelle
- Postinor
|
No information available |
|
| Vanuatu |
No information available |
No information available |
No information available |
- No information on product availability
|
No information available |
|
| Venezuela |
EC socially marketed by PROSALUD. |
Available over-the-counter in pharmacies. |
No information available |
- Escinor 0.75
- Glanique
- NorLevo 0.75mg
- Postinor 1
- Postinor-2
|
Available without a prescription |
|
| Vietnam |
Included in National RH Standards and Guidelines. Dedicated products registered. Total Contraceptive Prevalence: 78.5% (2002, WHO) |
FP clinics, without a prescription at pharmacies |
PATH |
- Ciel
- Escapelle
- Postinor-2
|
Available without a prescription |
|
| Yemen |
Registered with Supreme Board of Drugs. Total Contraceptive Prevalence: 20.8% (1997, WHO) |
EC is available in the public and private sector. EC is available in social marketing/NGO facilities. |
No information available |
- Duet
- Postinor-2
|
Available with unknown requirements |
|
| Zambia |
MOH FP Guidelines in March 1997, FP guidelines updated in 2006.
DHS Data 2007: Knowledge of EC-9.3%
Ever used EC-0.5% (all women), 0.7% (unmarried sexually active women) |
Private clinics, available from pharmacies without a prescription. EC is available in the public sector. EC is not available in social marketing/NGO facilities. |
JSI, IPPF affiliate, PSI (Society for Family Health), Ecafrique |
- Lenor 72
- Pregnon
|
Available without a prescription |
|
| Zimbabwe |
Included in MOH FP Guidelines.
DHS Data 1999: Knowledge of EC- 11.2%
Ever used EC- 0.6% (all women), 0.3% (unmarried sexually active women) |
EC is not available in the public sector. EC is available in social marketing/NGO facilities. |
PSI |
- Postinor-2
- Pregnon
|
Available with unknown requirements |
|
